Table 1.
Clinical Pathway | Clopidogrel n=9,291
|
Ticagrelor n=9,333
|
||
---|---|---|---|---|
N | Proportion | N | Proportion | |
1. No Events | 8,226 | 0.8854 | 8,432 | 0.9035 |
2. MI | 485 | 0.0522 | 421 | 0.0451 |
3. Stroke | 74 | 0.0080 | 81 | 0.0087 |
4. Dead any cause | 506 | 0.0545 | 399 | 0.0428 |
Note: Copyright © 2013. Oxford University Press. Reproduced from Nikolic E, Janzon M, Hauch O, Wallentin L, Henriksson M. Cost-effectiveness of treating acute coronary syndrome patients with ticagrelor for 12 months: results from the PLATO study. Eur Heart J. 2013;34(3):220–228 by permission of Oxford University Press.12
Abbreviation: MI, myocardial infarction.